NIDA Plans $10M for Addiction Genomics Research | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Drug Abuse will give $10 million in 2010 to fund deep sequencing studies aimed at identifying SNP variants and structural variants that may affect addiction risk in samples that are known to have drug abuse phenotypes.

NIDA plans to issue up to four grants of as much as $2.5 million per year for five years for research that will explore particular pharmacogenomic regions already identified by genome-wide association studies and other means and which could benefit from deep next-generation sequencing and analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.